Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Kyobu Geka ; 64(10): 947-9, 2011 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-21899136

RESUMO

We report a case of left traumatic diaphragmatic hernia in the postoperative state of the lung cancer. A 68-year-old man underwent video-assisted partial resection of the left lung for lung cancer. One year after the operation, he experienced an accident of falling from a tree. Chest radiograph and chest computed tomography revealed the stomach herniating into the left thoracic cavity. An emergent operation was performed by the abdominal approach. The stomach was returned into the abdominal cavity, and the hiatus in the central tendon of the left diaphragm was primarily sutured. The postoperative course was uneventful.


Assuntos
Hérnia Diafragmática Traumática , Neoplasias Pulmonares/cirurgia , Idoso , Hérnia Diafragmática Traumática/cirurgia , Humanos , Masculino , Pneumonectomia , Complicações Pós-Operatórias , Período Pós-Operatório
2.
Gan To Kagaku Ryoho ; 38(3): 423-5, 2011 Mar.
Artigo em Japonês | MEDLINE | ID: mdl-21403446

RESUMO

We report a 50-year-old female with pulmonary metastases from breast cancer who responded to S-1. In September 2003, she underwent surgery for breast cancer. Four years 8 months after the operation, lung relapse was detected. After the treatment failure of FEC60 (5-FU 500 mg/m², epirubicin 60 mg/m², cyclophosphamide 500 mg/m²) and taxane antitumor drugs, oral administration of S-1 80 mg/body/day was initiated. At the end of three courses, thoracic CT revealed the disappearance of the lung metastasis. Advanced reactions during the administration period were mild. After 14 courses of S-1 therapy (during 11 months), a complete response was clinically maintained. S-1 showed a good antitumor effect and tolerance, and it might be useful for treating metastatic and recurrent breast cancers.


Assuntos
Antimetabólitos Antineoplásicos/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Ácido Oxônico/uso terapêutico , Tegafur/uso terapêutico , Neoplasias da Mama/patologia , Combinação de Medicamentos , Feminino , Humanos , Neoplasias Pulmonares/secundário , Pessoa de Meia-Idade , Tomógrafos Computadorizados
3.
Gan To Kagaku Ryoho ; 34(11): 1869-72, 2007 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-18030027

RESUMO

We reported a case of unresectable gastric cancer presenting pylorus stenosis treated orally by S-1 therapy in a 72-year-old man who underwent gastrojejunostomy. He was admitted to our hospital complaining of appetite loss and body weight loss. Detailed examination showed gastric cancer with pylorus stenosis. After insertion of the naso-gastric tube with washing, a laparotomy was done. The operative findings revealed sT3, sN2, sP1, sH0 and sM1 (metastases of No. 14a lymph nodes invading the super mesenteric artery and pancreas) as an unresectable case with stage IV. Gastrojejunostomy and Braun anastomosis were made through the antecolic route. After the operation, intake therapy of S-1 was started (80-100 mg/body/dayx28 days). After 2 courses of the therapy, gastrointestinal fiber showed clinically a partial response of the main tumor. After 3 courses of this treatment, the tumor presented multiple liver metastases as a clinically progressive disease state. Paclitaxel therapy was conducted at a dose of 80 mg/body/weekx3 timesx2 courses. The patient had no effective benefits from the treatment and died of the cancer. He had survived 9 months, and the intervals of the intake and home stay were 7.5 months and five months, respectively, after the operation with no side effect of the chemotherapy. Survival was no longer than for patients only operated without S-1 therapy.


Assuntos
Antimetabólitos Antineoplásicos/administração & dosagem , Derivação Gástrica , Linfonodos/patologia , Ácido Oxônico/administração & dosagem , Piloro/patologia , Neoplasias Gástricas/tratamento farmacológico , Tegafur/administração & dosagem , Administração Oral , Idoso , Constrição Patológica , Vias de Administração de Medicamentos , Combinação de Medicamentos , Humanos , Metástase Linfática , Masculino , Artéria Mesentérica Superior/patologia , Invasividade Neoplásica , Neoplasias Pancreáticas/patologia , Neoplasias Gástricas/patologia , Neoplasias Gástricas/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA